Market Cap 12.86B
Revenue (ttm) 739.02M
Net Income (ttm) -436.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -59.05%
Debt to Equity Ratio -3.14
Volume 3,757,300
Avg Vol 2,690,954
Day's Range N/A - N/A
Shares Out 126.04M
Stochastic %K 11%
Beta 1.58
Analysts Strong Sell
Price Target $102.76

Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-pow...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 855 698 8887
Fax: 888 974 4258
Address:
3100 Hanover Street, Palo Alto, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:20 AM
Actionable Trade Alert for $GH: Market Context: $GH is currently trading at $108.52, showing strong momentum with an RSI of 72.32, indicating overbought conditions. However, the price is above the 30-day moving average (MA30) of 95.46 and the 50-day moving average (MA50) of 82.88, suggesting a bullish trend. Directional Bias: The price is nearing the 60-day high of $112.43, providing a potential resistance level. Given the RSI and the proximity to the high, a pullback may occur, but the overall trend remains bullish. Trade Plan: - Suggested Entry: $108.52 - Stop Loss: $104.00 (below recent support) - Take Profit Targets: 1. $111.00 (2.3% ROI) 2. $113.50 (4.5% ROI) 3. $127.00 (17% ROI) This plan allows for a strategic entry with a favorable risk-reward profile, targeting significant upside potential while managing risk effectively. https://privateprofiteers.com
0 · Reply
Gator5326
Gator5326 Dec. 6 at 12:03 AM
$GH looks like some insiders sold some shares. End of year tax planning imo. They sold a small percentage compared to what they own. looks like those guys hit a homerun!
0 · Reply
justiceforb_85
justiceforb_85 Dec. 5 at 11:36 PM
$GH adding on this dip. Seems unwarranted.
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 9:54 PM
Actionable Trade Alert for $GH: Market Context: $GH is currently trading at $108.52, showing strong momentum with an RSI of 72.32, indicating overbought conditions. However, the price is above the 30-day moving average (MA30) of 95.46 and the 50-day moving average (MA50) of 82.88, suggesting a bullish trend. Directional Bias: The price is nearing the 60-day high of $112.43, providing a potential resistance level. Given the RSI and the proximity to the high, a pullback may occur, but the overall trend remains bullish. Trade Plan: - Suggested Entry: $108.52 - Stop Loss: $104.00 (below recent support) - Take Profit Targets: 1. $111.00 (2.3% ROI) 2. $113.50 (4.5% ROI) 3. $127.00 (17% ROI) This plan allows for a strategic entry with a favorable risk-reward profile, targeting significant upside potential while managing risk effectively. https://privateprofiteers.com
0 · Reply
investtrade13
investtrade13 Dec. 5 at 7:20 PM
$GH what happened at 11 AM?
1 · Reply
Gator5326
Gator5326 Dec. 5 at 5:10 PM
$GH News this morning. https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZ-2FtX741n0Z6WOyiD4GHhsE2ot5GqmAvyBExw8uY-2BwbjPCMXcYuWP9IxkbQPLLbas-2BDNf-2FRbfMUxngAds7CKx7gHJI4aoA22T7qABr6nPXUoRmd-2BvFd-2FjOgNxnZNgg0Hr-2B-2B3ArywY5SZX2o-2FhTNWrQZnJShWk3jXSybAZkea690Wu0DrE51aRBYdVOT6KpioIpA7INYLci3DGciicgPJgV8WHLUI6G-2Bju8kWPsCoJqd4ysO02OYN34QA-2Fl39pt5sGW-2FAv3aLYerMX08ux5B-2F6IDdRGEwZO704Hs4I-2BPqPmT4eIZac0Bc-2BBVT0CXlAKUNVO60omiAGor58CBcrGtWW2gMaPze3yu4W3U5yhfbQUi4y38pS_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMhK6PExu0pIasli2MI-2Bd2bF2O8SCmwDsz-2BxaqAzufx4reCH2yCSFOTDz0SaLqiBeXC4aOYzEYf-2BDYsnDosHSyp8hevWHq-2F5-2BNzXd3KbFii00hRBZ-2Fp6Jbjj68QsiefLgIqbqXu1VwM6yDQ27MhvLt2fVMN-2F3wttqntymEtbAwrATMt0G-2FChYCNj-2B8NMfcpD8kNXL7EZ49XNSeSMrGrccS585WckDN5trdcWJ1nMj8s7fAao6RdBH1VbfvFU81gNFq9QtfhaU-2B-2BUEVn9PqugHFlVOKave3NuMIZuKCm-2Fz6tpHMDNid-2BNMSFeJBN3Y4LbiV079d4se98-2BSdBl22tDQxijaKufzlZ1oaL-2BDM8moh2kBnby38wDtUQZD6V4-2FZU1MnQgIFnphVVDRY76lHnaVuPV4QChyL180ArF-2B9XX6nCBUiqjamlLjiBrSVQjeoiAj1xImpSDpBnwPDbHILnnd904-3D
0 · Reply
Eskayes
Eskayes Dec. 5 at 4:06 PM
$GH what’s the news here?
0 · Reply
G101SPM
G101SPM Dec. 5 at 1:15 PM
$GH $108.52 Core holding BRIEF: Guardant Health to present 14 abstracts demonstrating the power of multiomic liquid biopsy tests in predicting outcomes and tailoring treatment for early and metastatic breast cancer at the 2025 San Antonio Breast Cancer Symposium .
0 · Reply
oaksapollo
oaksapollo Dec. 4 at 4:56 PM
$GH and $NTRA have a combined cap of nearly $50B now, while shares of poor neglected $LUCD can be purchased for $1 ($140M cap). Pretty crazy given they are the only player in the $30B esophageal cancer screening space. There is no questioning the TAM - pricing has already been set by CMS at $1932 and there are good data defining the screening population at 30M people (per ACG guidance). And yes, I know, their history is not glamorous. IPO’d at $14 and traded to pennies, but after a long journey they are finally on the cusp of broad coverage with all of the GI community rooting for them. Test volume and revenue will scale quickly.
0 · Reply
Academia
Academia Dec. 4 at 8:33 AM
$GH $XLV $SPY Taking 85% off the table at open! Nice swing 👌
0 · Reply
Latest News on GH
5 Top Stocks For AI Fatigue

Nov 28, 2025, 11:47 AM EST - 8 days ago

5 Top Stocks For AI Fatigue

AMBP GSL OHI PARR


6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 18 days ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN MEDP WGS


Why Guardant Health Was Such an Investor Darling This Week

Oct 31, 2025, 5:45 AM EDT - 5 weeks ago

Why Guardant Health Was Such an Investor Darling This Week


Guardant Health: Business Continues To Gather Pace

Oct 30, 2025, 9:03 PM EDT - 5 weeks ago

Guardant Health: Business Continues To Gather Pace


Why Guardant Health Stock Surged Today

Oct 30, 2025, 6:56 PM EDT - 5 weeks ago

Why Guardant Health Stock Surged Today


Guardant Health, Inc. (GH) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 1:46 AM EDT - 5 weeks ago

Guardant Health, Inc. (GH) Q3 2025 Earnings Call Transcript


Guardant Health, Inc. (GH) Analyst/Investor Day Transcript

Sep 24, 2025, 7:17 PM EDT - 2 months ago

Guardant Health, Inc. (GH) Analyst/Investor Day Transcript


Alex M. Azar II Joins Guardant Health Board of Directors

Sep 15, 2025, 4:07 PM EDT - 2 months ago

Alex M. Azar II Joins Guardant Health Board of Directors


Guardant Health to Host Investor Day on September 24, 2025

Aug 28, 2025, 4:05 PM EDT - 3 months ago

Guardant Health to Host Investor Day on September 24, 2025


Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 11:13 AM EDT - 4 months ago

Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript


Guardant Health (GH) Q2 Revenue Up 31%

Jul 31, 2025, 5:06 AM EDT - 4 months ago

Guardant Health (GH) Q2 Revenue Up 31%


Why Guardant Health Stock Surged Nearly 9% Higher Today

Jun 3, 2025, 5:48 PM EDT - 6 months ago

Why Guardant Health Stock Surged Nearly 9% Higher Today


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:20 AM
Actionable Trade Alert for $GH: Market Context: $GH is currently trading at $108.52, showing strong momentum with an RSI of 72.32, indicating overbought conditions. However, the price is above the 30-day moving average (MA30) of 95.46 and the 50-day moving average (MA50) of 82.88, suggesting a bullish trend. Directional Bias: The price is nearing the 60-day high of $112.43, providing a potential resistance level. Given the RSI and the proximity to the high, a pullback may occur, but the overall trend remains bullish. Trade Plan: - Suggested Entry: $108.52 - Stop Loss: $104.00 (below recent support) - Take Profit Targets: 1. $111.00 (2.3% ROI) 2. $113.50 (4.5% ROI) 3. $127.00 (17% ROI) This plan allows for a strategic entry with a favorable risk-reward profile, targeting significant upside potential while managing risk effectively. https://privateprofiteers.com
0 · Reply
Gator5326
Gator5326 Dec. 6 at 12:03 AM
$GH looks like some insiders sold some shares. End of year tax planning imo. They sold a small percentage compared to what they own. looks like those guys hit a homerun!
0 · Reply
justiceforb_85
justiceforb_85 Dec. 5 at 11:36 PM
$GH adding on this dip. Seems unwarranted.
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 9:54 PM
Actionable Trade Alert for $GH: Market Context: $GH is currently trading at $108.52, showing strong momentum with an RSI of 72.32, indicating overbought conditions. However, the price is above the 30-day moving average (MA30) of 95.46 and the 50-day moving average (MA50) of 82.88, suggesting a bullish trend. Directional Bias: The price is nearing the 60-day high of $112.43, providing a potential resistance level. Given the RSI and the proximity to the high, a pullback may occur, but the overall trend remains bullish. Trade Plan: - Suggested Entry: $108.52 - Stop Loss: $104.00 (below recent support) - Take Profit Targets: 1. $111.00 (2.3% ROI) 2. $113.50 (4.5% ROI) 3. $127.00 (17% ROI) This plan allows for a strategic entry with a favorable risk-reward profile, targeting significant upside potential while managing risk effectively. https://privateprofiteers.com
0 · Reply
investtrade13
investtrade13 Dec. 5 at 7:20 PM
$GH what happened at 11 AM?
1 · Reply
Gator5326
Gator5326 Dec. 5 at 5:10 PM
$GH News this morning. https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZ-2FtX741n0Z6WOyiD4GHhsE2ot5GqmAvyBExw8uY-2BwbjPCMXcYuWP9IxkbQPLLbas-2BDNf-2FRbfMUxngAds7CKx7gHJI4aoA22T7qABr6nPXUoRmd-2BvFd-2FjOgNxnZNgg0Hr-2B-2B3ArywY5SZX2o-2FhTNWrQZnJShWk3jXSybAZkea690Wu0DrE51aRBYdVOT6KpioIpA7INYLci3DGciicgPJgV8WHLUI6G-2Bju8kWPsCoJqd4ysO02OYN34QA-2Fl39pt5sGW-2FAv3aLYerMX08ux5B-2F6IDdRGEwZO704Hs4I-2BPqPmT4eIZac0Bc-2BBVT0CXlAKUNVO60omiAGor58CBcrGtWW2gMaPze3yu4W3U5yhfbQUi4y38pS_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMhK6PExu0pIasli2MI-2Bd2bF2O8SCmwDsz-2BxaqAzufx4reCH2yCSFOTDz0SaLqiBeXC4aOYzEYf-2BDYsnDosHSyp8hevWHq-2F5-2BNzXd3KbFii00hRBZ-2Fp6Jbjj68QsiefLgIqbqXu1VwM6yDQ27MhvLt2fVMN-2F3wttqntymEtbAwrATMt0G-2FChYCNj-2B8NMfcpD8kNXL7EZ49XNSeSMrGrccS585WckDN5trdcWJ1nMj8s7fAao6RdBH1VbfvFU81gNFq9QtfhaU-2B-2BUEVn9PqugHFlVOKave3NuMIZuKCm-2Fz6tpHMDNid-2BNMSFeJBN3Y4LbiV079d4se98-2BSdBl22tDQxijaKufzlZ1oaL-2BDM8moh2kBnby38wDtUQZD6V4-2FZU1MnQgIFnphVVDRY76lHnaVuPV4QChyL180ArF-2B9XX6nCBUiqjamlLjiBrSVQjeoiAj1xImpSDpBnwPDbHILnnd904-3D
0 · Reply
Eskayes
Eskayes Dec. 5 at 4:06 PM
$GH what’s the news here?
0 · Reply
G101SPM
G101SPM Dec. 5 at 1:15 PM
$GH $108.52 Core holding BRIEF: Guardant Health to present 14 abstracts demonstrating the power of multiomic liquid biopsy tests in predicting outcomes and tailoring treatment for early and metastatic breast cancer at the 2025 San Antonio Breast Cancer Symposium .
0 · Reply
oaksapollo
oaksapollo Dec. 4 at 4:56 PM
$GH and $NTRA have a combined cap of nearly $50B now, while shares of poor neglected $LUCD can be purchased for $1 ($140M cap). Pretty crazy given they are the only player in the $30B esophageal cancer screening space. There is no questioning the TAM - pricing has already been set by CMS at $1932 and there are good data defining the screening population at 30M people (per ACG guidance). And yes, I know, their history is not glamorous. IPO’d at $14 and traded to pennies, but after a long journey they are finally on the cusp of broad coverage with all of the GI community rooting for them. Test volume and revenue will scale quickly.
0 · Reply
Academia
Academia Dec. 4 at 8:33 AM
$GH $XLV $SPY Taking 85% off the table at open! Nice swing 👌
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 6:31 PM
$GH Current Stock Price: $106.83 Contracts to trade: $105 GH Dec 19 2025 Call Entry: $6.00 Exit: $10.72 ROI: 79% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
NJ125
NJ125 Dec. 2 at 11:53 PM
$GH double whammy inputs today: 1. Morgan Stanley report out with 12 month target price of $130. Looks like Morgan Stanley may have helped someone buy up almost a million shares. 2.Note that Senator Sheldon Whitehouse filed on HIS recent purchase of GH shares. Following in Nancy Pelosi footsteps does he have magic predictive views of good things coming for GH . What does he see from his committee’s vantage points????
1 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:40 PM
Morgan Stanley has updated their rating for Guardant Health ( $GH ) to Overweight with a price target of 130.
0 · Reply
justiceforb_85
justiceforb_85 Dec. 2 at 5:16 PM
$GH congressman bought. Decent future outlook so I will be adding.
0 · Reply
G101SPM
G101SPM Dec. 2 at 1:32 PM
$GH $106.09 bid One of the Crown Jewels of the G-101 SPM portfolio originally pick at $18.22 on March 14, 2024. https://stocktwits.com/G101SPM/message/565869167. BRIEF: Guardant Health (GH) assumed with an Overweight at Morgan Stanley, tgt $130 .
0 · Reply
Gator5326
Gator5326 Nov. 28 at 1:45 PM
$GH closer to $200 by end of next year 😎
0 · Reply
Gator5326
Gator5326 Nov. 28 at 1:44 PM
0 · Reply
123rs123
123rs123 Nov. 27 at 4:48 AM
$GH $107 already ;)
1 · Reply
G101SPM
G101SPM Nov. 26 at 7:24 PM
$ARWR $57.93 +11.14. DAC (dollar average cost includes partial SELLS to reduce net cost to $​1.96. As with $GH , $ARWR is classic example why G-101 SPM Positional Strategists format is the top investment platform for the last three years with a 87.91% successful value idea score to date 1000 shares at 14.41 cost $14,410. https://stocktwits.com/G101SPM/message/614403674 After partial SELLS and REVISITS the net position is worth $412,359 , 2.23 AM 11.26.25 This class example as a Positional Strategist is not an isolated feat, but a continuing pattern why the G-101 SPM AI algorithm has not equal. Check for yourself. We call it complete transparence. $ARWR
0 · Reply
Albino_Trader123
Albino_Trader123 Nov. 26 at 4:41 PM
$GRAL $GH $BIIB $REGN these names been paying well during this chop
0 · Reply
G101SPM
G101SPM Nov. 26 at 12:22 PM
$SPY $GH is a classic example why G-101 SPM Positional Strategists format is the top investment platform for the last three years with a 87.36% successful value idea score on over 2107 postings. $GH ​109.02 bid has a net value cost of $16.49 on ten transactions (fully documented on this platform) with the first beginning on March 14, 2024. https://stocktwits.com/G101SPM/message/565869167 1000 shares at 16.49 cost $16,490. After partial SELLS and REVISITS the net position is worth $945.345. as of 7:20 AM 11.26.25 This class example as a Positional Strategist is not an isolated feat, but a continuing pattern why the G-101 SPM AI algorithm has not equal. Check for yourself. We call it complete transparence.
0 · Reply
Brianum2011
Brianum2011 Nov. 26 at 12:50 AM
$GH $GRAL Which one do you take for long term hold?
2 · Reply